Resveratrol provides cardioprotection after ischemia/reperfusion injury via modulation of antioxidant enzyme activities

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 4, 2013, Pages 867-875

  Mokni, Meherzia ^a   Hamlaoui, Sonia ^a   Karkouch, Ines ^b   Amri, Mohamed ^a   Marzouki, Lamjed ^a   Limam, Ferid ^b   Aouani, Ezzedine ^b  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE BORJ CÉDRIA   (Tunisia)

Author keywords

Antioxidant enzyme isoforms; Catalase; Free iron; Heart; Ischemia reperfusion injury; MDA; Peroxidase; Resveratrol; Superoxide dismutase

Indexed keywords

CATALASE; IRON; ISOENZYME; PEROXIDASE; RESVERATROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEMODYNAMIC PARAMETERS; LIPID PEROXIDATION; MALE; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; NONHUMAN; RAT; REPERFUSION INJURY;

EID: 84888082326     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Manzanero S, Santro T and Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochem Int. (2012) 62: 712-718.
2. Michel F, Bonnefont-Rousselot D, Mas E, Drai J and Thérond P. Biomarkers of lipid peroxidation: analytical aspects. Ann Biol Clin (Paris). (2008) 66: 605-20.
3. Ren S, Lien EJ. Natural products and their derivatives as cancer chemopreventive agents. Prog. Drug Res. (1997) 48: 147-71.
4. Maksimenko AV and Vavaev AV. Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart Int. (2012) 7(e3): 14-19.
5. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health-a comprehensive review of human clinical trials. Mol Nutr Food Res. (2011) 55: 1129-41.
6. Mokni M, Elkahoui S, Limam F, Amri M and Aouani E. Effect of Resveratrol on Antioxidant Enzyme Activities in the Brain of Healthy Rat. Neurochem Res. (2007) 32: 981-987.
7. Mokni M, Limam F, Elkahoui S, Amri M and Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch Biochem Biophys. (2007) 457: 1-6.
8. Leardi A, Caraglia M, Selleri C, Pepe S, Pizzi C, Notaro R, Fabbrocini A, De Lorenzo S, Musico M, Abbruzzesé A, Bianco AR and Tagliaferri P. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. Brit J. Hematol. (1998) 102: 746-752.
9. Draper HH and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. (1990) 186: 421-431.
10. Aebi H. Catalase in-vitro. Methods Enzymol. (1984) 105: 121-126.
11. Chance B ans Maehly AC, Assay of catalases and peroxidases. Methods Enzymol. (1955) 2: 764-817.
12. Misra HP and Fridovich I. The role of superoxide anion in autoxidation of epinephrine and a simple assay for SOD. J Biol Chem. (1972) 247: 3170-3175.
13. Davis BJ. Disc electrophoresis II. Method and application to human serum proteins. Ann. N. Y. Acad Sci. (1964) 121: 404-427.
14. Reisfeld JC, Lewis UJ and Williams DE. Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature. (1962) 195: 281-283.
15. Beauchamp C and Fridovitch I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. (1971) 44: 276-287.
16. Loukhili A, Limam F, Ayadi A, Boyer N and Ouelhazi L. Purification and characterization of a neutral peroxidase induced by rubbing tomato internodes. Physiol Plant. (1999) 105: 24-31.
17. Woodburry W, Spencer AK and Stahmann MA. An improved procedure using ferricyanide for detecting catalase isoenzymes. Anal Biochem. (1971) 44: 301-305.
18. Lee DL, Kim YS and Lee CB. The inductive responses of the antioxidant enzymes by salt stress in the rice (Oryza sativa L). J. Plant Physiol. (2001) 158: 737-745.
19. Hung LM, Chen JK, Huang SS, Lee RS and Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res. (2000) 47: 549-555.
20. De Lorgeril M, Salen P, Guiraud A, Boucher E and de Leiris J. Resveratrol and non-ethanolic components of wine in experimental cardiology. Nutr. Metab. Cardiovasc Dis. (2003) 13: 100-103.
21. Uchiyama S, Shimizu T and Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J. Biol. Chem. (2006) 281: 31713-31719.
22. Sebai H, Ben Attia M, Sani M, Aouani E and Ghanem Boughanmi N. Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism. Free Radic. Res. (2008) 42: 913-920.
23. Aryeh Shander, Ulrike Berth, Joanne Betta and Mazyar Javidroozi. Iron overload and toxicity: implications for anaesthesiologists. Review Article J. Clinical Anesthesia. (2012). 24: 419-425.
24. Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F and Ackerley C. Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP, Bachx PH. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nature. Med. (2003) 9: 1187-1194.
25. Zhang Y, Liu Y, Wang T, Li B, Li H, Wang Z and Wang B. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Com. (2006) 340: 1192-1199.
26. Merle U, Fein E, Gehrke SG, Stremmel W and Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinol. (2007) 148: 2663-2668.
27. Isoda M, Hariawa H, Watarrabe R, Yoshida T, Toba K, Yoshida K, Kojima M, Hao K, Ding L, Tarrak K, Takayama T, Kato K, Okura Y, Kodama M, Ota Y, Hayashi J and Aizawa Y. Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction. J. Nutr. Biochem. (2009) 21: 749-756.
28. Leopoldini M, Russo N, Chiodo S and Toscano M. Iron chelation by the powerful antioxidant flavonoid quercetin. J. Agric. Food Chem. (2006) 54: 6343-6351.
29. Dong FW and Richardson Des R. Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood. (2007) 110: 752-761.
30. Gérard Lescoat, Stéphane Léonce, Alain Pierré, Lucie Gouffier and François Gaboriau. Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures. Chemico-Biological Interactions. (2012). 195: 165-172.
31. Heck DE, Vetrano AM, Marrano TM and Laskin JD. UVB light stimulates production of reactive oxygen species: unexpected role for catalase. J. Biol. Chem. (2003) 27: 22432-22436.
32. Archambaud C, Nahoir MA, Piazarro-Cerda J, Cossart P and Dussurget O. Control of Listeria superoxide dismutase by phosphorylation. J. Biol. Chem. (2006) 281: 31812-31822.
33. Chang TS, Jeong W, Chai SY, Yu S, Kang SW and Rhee SG. Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. J. Biol. Chem. (2002) 277: 25370-25376.
34. Murtaza I, Wang HX, Feng X, Alenina N, Bader M, Prabhakar B and Li PF. Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy. J. Biol. Chem. (2008) 283: 5996-6004.
35. Gadacha W, Ben Attia M, Bonnefont-Rousselot D, Aouani E, Ghanem-Boughanmi N and Touitou Y. Resveratrol opposite effects on rat tissue lipoperoxidation: pro-oxidant during day-time and antioxidant at night. Redox Rep. (2009) 14: 154-158.